Giovanni Maga

发表

A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors.

Fabrizio Manetti, Maurizio Botta, Stefano Forli, 2006, Journal of medicinal chemistry.

Proliferating cell nuclear antigen (PCNA): a dancer with many partners

G. Maga, U. Hübscher, Giovanni Maga, 2003, Journal of Cell Science.

Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymes.

Rino Ragno, Flavio Ballante, Roberto Cirilli, 2014, Journal of medicinal chemistry.

Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication

Maurizio Zazzi, Fausto Baldanti, F. Baldanti, 2004, Antimicrobial Agents and Chemotherapy.

A Multidisciplinary Approach for the Identification of Novel HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors: S‐DABOCs and DAVPs

Maurizio Botta, Marco Radi, Mercedes Armand-Ugón, 2008, ChemMedChem.

Human Proliferating Cell Nuclear Antigen, Poly(ADP-ribose) Polymerase-1, and p21waf1/cip1

G. Maga, M. Savio, F. Riva, 2003, Journal of Biological Chemistry.

2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studies.

Ira Musmuca, Rino Ragno, Flavio Ballante, 2012, Journal of medicinal chemistry.

Human DNA Polymerase Functionally and Physically Interacts with Proliferating Cell Nuclear Antigen in Normal and

Consejo Superior de Investigaciones, G. Maga, L. Blanco, 2002 .

Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor.

Barbara Gatto, Jan Paeshuyse, Giuseppe Manfroni, 2009, Journal of medicinal chemistry.

Design and Synthesis of Thiadiazoles and Thiazoles Targeting the Bcr‐Abl T315I Mutant: from Docking False Positives to ATP‐Noncompetitive Inhibitors

Fabrizio Manetti, Maurizio Botta, Marco Radi, 2010, ChemMedChem.

Identification of host cell factors involved in influenza A virus infection

G. Maga, L. Bavagnoli, Giovanni Maga, 2013 .

N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds.

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2008, Bioorganic & medicinal chemistry letters.

Current state-of-the-art in preclinical and clinical development of novel non-nucleoside HIV-1 reverse transcriptase inhibitors

Romano Silvestri, G. Maga, R. Silvestri, 2006 .

Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.

Jan Balzarini, Angela Rao, Maria Zappalà, 2005, Journal of medicinal chemistry.

Slow‐, Tight‐Binding HIV‐1 Reverse Transcriptase Non‐Nucleoside Inhibitors Highly Active against Drug‐Resistant Mutants

Gianluca Sbardella, Antonello Mai, Imma Clotet-Codina, 2007, ChemMedChem.

Substrate‐Induced Stable Enzyme–Inhibitor Complex Formation Allows Tight Binding of Novel 2‐Aminopyrimidin‐4(3H)‐ones to Drug‐Resistant HIV‐1 Reverse Transcriptase Mutants

Antonello Mai, Mercedes Armand-Ugón, José A. Esté, 2008, ChemMedChem.

Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors.

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2009, Bioorganic & medicinal chemistry letters.

Structure‐Based Pharmacophore Identification of New Chemical Scaffolds as Non‐Nucleoside Reverse Transcriptase Inhibitors.

Angela Rao, Alba Chimirri, Nunzio Iraci, 2007 .

3D QSAR Models Built on Structure‐Based Alignments of Abl Tyrosine Kinase Inhibitors

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2009, ChemMedChem.

How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?

Anna Garbelli, E. Crespan, G. Maga, 2017, The Biochemical journal.

Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.

Ettore Novellino, Caterina Fattorusso, Giuseppe Campiani, 2002, Current pharmaceutical design.